StockGlow

BioNTech SE (22UA.F)

Develops mRNA vaccines and cancer treatments using genetic technology.

80.35+0.01%Healthcare
Compare 22UA.F with
StockGlow Score
40
Neutral
BearishBullish
1 year ago-12.0%

The outlook

BioNTech is trading near the lower end of its 52-week range, currently around 33% up from its low. The stock sits mixed relative to its moving averages, with analyst coverage showing a neutral lean overall. Today's movement was essentially flat.

What’s behind the score

Price trendMixed vs its moving averages
52-week range33% of the way from its 52-week low to high
Market cap
$20.32B
52-wk high
105.50
52-wk low
68.00
50-day avg
79.23
200-day avg
84.34
Trailing P/E
—

Similar stocks

0QF.FModerna, Inc.$48.45+1.60%D7G.FNel ASA$0.19-0.83%NVV1.FNovavax, Inc.$6.44-0.92%27W.FPowerCell Sweden AB (publ)$1.78+1.37%BY6.FBYD Company Limited$10.37+2.23%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy